Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        OCE Annual Reports

2022 OCE Annual Report

                        
                Modernizing  Evidence Generation
          Oncology Regulatory Review
          Community and Patient Outreach
          Professional Education
          Other Professional Resources Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          OCE Annual Reports
          2022 OCE Annual ReportOCE Annual Reports 2022 OCE Annual Report
  	
        Share
    Post
    Linkedin

    Email
    PrintImage
              2022 AR MainOCE Director's Message

Dr Pazdur
After five years of tremendous growth since its formation in 2017, the Oncology Center of Excellence slowed the launch of new projects in 2022 to allow existing projects to grow in depth and strength.

This year, our work examined several ways the OCE could leverage its resources to modernize evidence generation in oncology drug development. That is, what could the OCE do to encourage the development of clinical trial data that responds to the modern needs of patients and their physicians. With the initiatives we began or strengthened this year, we aim to:

Ensure that clinical trial participants adequately reflect the demographic representation of patients with cancer for whom the products are intended—FDA’s draft Diversity Plans guidance, led by Project Equity.
	Open and complete clinical trials more quickly, using less complex trial designs seeking answers to clinical questions important to patients and their doctors—Project Pragmatica.
	Explore the potentially more efficient development of drugs for cancers defined by molecular alterations—Tissue Agnostic Drug Development Program and draft guidance document.
	Reform the dose optimization and dose selection paradigm in oncology drug development to maximize not only the efficacy of a drug but the safety and tolerability as well—Project Optimus.
	Address the problem of outdated labeling of older oncology drugs by assessing publicly available information that may support updates to FDA-approved product labeling—Project Renewal.Please explore our 2022 Annual Report to learn more about the OCE’s work. I hope you will be inspired to take part in our programs and projects to improve the lives of patients with cancer.

**Richard Pazdur, M.D.*****Director, Oncology Center of Excellence***

NEXT

                                                                                  Content current as of:
      02/03/20232022 OCE Annual Report                
                          

                        Modernizing  Evidence Generation
          Oncology Regulatory Review
          Community and Patient Outreach
          Professional Education
          Other Professional Resources
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop